Nuvectis Pharma Inc (NVCT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $8.94
• Market Cap: $230.48M
• EPS: $-1.32
• 52-Week High: $11.52
• 52-Week Low: $5.55

Market Sentiment

Nuvectis Pharma Inc currently has a Neutral sentiment score of 0.11.

About Nuvectis Pharma Inc

Nuvectis Pharma, Inc. (NVCT) is a biopharmaceutical company based in Fort Lee, New Jersey, specializing in the development of targeted small molecule therapies for cancer treatment. The company boasts a promising pipeline that utilizes cutting-edge drug discovery technologies, setting the stage for innovative solutions that aim to improve both the efficacy and tolerability of cancer therapies. With a strong commitment to precision medicine and scientific rigor, Nuvectis is well-positioned to ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Nuvectis Pharma Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NVCT pay dividends?

Nuvectis Pharma Inc (NVCT) does not currently pay a regular dividend.

What is NVCT's market cap?

Nuvectis Pharma Inc (NVCT) has a market capitalization of $230.48M with a current stock price of $8.94.